- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02355808
Do Superfast Broadband and Tailored Interventions Improve Use of E-health and Reduce Health Related Travel? (SUPFASTEHEALTH)
January 30, 2015 updated by: Philip Abbott-Garner, University of Plymouth
Lack of internet infrastructure, personal skills, and service provision have been identified as potential barriers to e-health but as yet there is no good evidence of the impact of interventions to improve them.
This study aims to assess impact on e-health uptake of three interventions (i) superfast broadband, (ii) a tailored leaflet to help participants improve personal internet skills and support, (iii) GP interventions to improve health service provision of e-health.
In a cluster randomised factorial controlled trial, 1388 households from 78 postcodes were randomly selected from the 20088 Cornish postcodes and allocated to the 8 (2X2X2) arms of the study.
Comparison of 'e-health readiness' and 'miles travelled' from baseline to 18 month follow-up between the 8 arms of the study, will be used to assess the effects of interventions, singly and in combination.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
1044
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 16+ and member of randomly selected household within Cornwall
Exclusion Criteria:
- Non Cornish households
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Non Superfast
|
|
Other: Non Superfast GP intervention
|
|
Other: Non Superfast Tailored Leaflet
|
|
Other: Non Superfast GP + Tailored Leaflet
|
|
No Intervention: Superfast
|
|
Other: Non Superfast GP
|
|
Other: Superfast Tailored Leaflet
|
|
Other: Superfast GP + Tailored Leaflet
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
PERQ Ehealth score
Time Frame: 18 month
|
18 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Anticipated)
April 1, 2015
Study Completion (Anticipated)
October 1, 2015
Study Registration Dates
First Submitted
January 30, 2015
First Submitted That Met QC Criteria
January 30, 2015
First Posted (Estimate)
February 4, 2015
Study Record Updates
Last Update Posted (Estimate)
February 4, 2015
Last Update Submitted That Met QC Criteria
January 30, 2015
Last Verified
January 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 12/13-144
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on eHealth
-
The University of Hong KongSino Group; NG TENG FONG Charitable FoundationNot yet recruiting
-
OnkoZentrum Zürich AGStiftung Swiss Tumor InstituteTerminatedTelemedicine | eHealthSwitzerland, Austria, Germany
-
Govert VeldhuijzenCompletedColonoscopy | eHealth | Education, Patient
-
Pennington Biomedical Research CenterCompletedeHealth | Breastfeeding | Energy IntakeUnited States
-
Jacobs University Bremen gGmbHMirjam Jansen; medmedia AcademyRecruitingeHealth | Patient Safety | Health Care ProvidersGermany
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)Not yet recruitingMental Health Wellness 1 | Self Efficacy | eHealth | Infant Development
-
Ain Shams UniversityRecruitingmHealth | eHealth | Oral HealthEgypt
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknown
-
Radboud University Medical CenterNot yet recruitingTelemedicine | eHealth | Wheezing
-
Amsterdam University of Applied SciencesAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); ZonMw: The...RecruitingStroke | Occupational Therapy | eHealthNetherlands
Clinical Trials on GP visit
-
University of AarhusCompletedModels of Care in the Transition From the Secondary to the Primary Sector Among the Frailest ElderlyFrail Elderly Syndrome | Frailty | Aging | Elderly | Readmission | Transitional CareDenmark
-
Krasnoyarsk Regional HospitalUnknownPathologic Processes | Heart Diseases | Cardiovascular Diseases | Lung Diseases | Atrial Fibrillation | Arrhythmias, Cardiac | Hypertension, Pulmonary
-
Sun Yat-sen UniversityNot yet recruiting
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
Sun Yat-sen UniversityRecruitingRecurrent or Metastatic Nasopharyngeal CarcinomaChina
-
Universitätsklinikum Hamburg-EppendorfRecruitingCoronary Disease | Diabetes Mellitus, Type 2 | Breast Neoplasms | Diabetes Mellitus, Type 1 | Pulmonary Disease, Chronic Obstructive | Asthma | Comorbidities and Coexisting ConditionsGermany
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
University of AarhusRecruitingUterine Cervical Neoplasm | Mass Screening | Uterine Cervical Disease | Uterine NeoplasmDenmark
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia BUnited States, Switzerland, Germany